REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 19 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,624,480 | -4.9% | 2,021,000 | +24.7% | 0.00% | – |
| Q2 2023 | $1,708,534 | -23.5% | 1,621,000 | -11.0% | 0.00% | – |
| Q1 2023 | $2,233,457 | -15.5% | 1,821,000 | -37.1% | 0.00% | – |
| Q4 2022 | $2,644,048 | -2.5% | 2,896,000 | +15.8% | 0.00% | – |
| Q3 2022 | $2,713,000 | +4.0% | 2,500,000 | -22.5% | 0.00% | – |
| Q2 2022 | $2,608,000 | +28.2% | 3,225,000 | +48.3% | 0.00% | – |
| Q1 2022 | $2,035,000 | +17.7% | 2,175,000 | +10.1% | 0.00% | – |
| Q4 2021 | $1,729,000 | -7.3% | 1,975,000 | +21.5% | 0.00% | – |
| Q3 2021 | $1,866,000 | -1.6% | 1,625,000 | 0.0% | 0.00% | – |
| Q2 2021 | $1,896,000 | +4.1% | 1,625,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,821,000 | – | 1,625,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |